erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hoarseness D006685 2 associated lipids
Occupational Injuries D060051 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Ermol'eva ZV et al. [Sensitivity of non-agglutinating vibrions to antibiotics]. 1969 Antibiotiki pmid:4185523
Agarunova IuS and Suteeva TG [On the sensitivity of pathogenic aerobic-Actinomyces to antibiotics and sulfanilamides]. 1966 Antibiotiki pmid:4871095
Garanin BA [Sensitivity toward antibiotics of enteropathogenic Escherichia coli. (According to data from a hospital for infectious diseases)]. 1967 Antibiotiki pmid:4871267
Klushina TN [Inhibitory action of antibiotics on the L-forms of diphteroids and some mycoplasms]. 1966 Antibiotiki pmid:4872318
Bass TM [Effect of ecmoline on the resistance of staphylococci to antibiotics]. 1973 Antibiotiki pmid:4491920
Rachovskaia IuK and Rodionova NS [The antibiotic sensitivity spectrum of strains of salmonella circulating in Rostov-on-Don]. 1974 Antibiotiki pmid:4282564
Vartanian ZhS [The eliminating effect of rifampicin and acriflavine on the determinants of antibiotics resistance in clinical strains of staphylococcus]. 1973 Antibiotiki pmid:4493701
Kuzina ZA and Tereshin IM [The effect of a series of antibiotics on nucleic acid and protein synthesis in Salmonella pullorum]. 1973 Antibiotiki pmid:4787727
Red'ko AF [Dynamics of the change of the composition of microflora and its sensitivity toward antibiotics in purulent inflammatory processes of lungs]. 1966 Antibiotiki pmid:4385185
VEIS RA and STOROZHEV Ia [On the pharmacology of erythromycin and its derivatives]. 1962 Antibiotiki pmid:13996561
Lazareva EN et al. [Erythromycin-ascorbinate--a drug for parenteral administration]. 1966 Antibiotiki pmid:5973448
Lobanova VV et al. [The use of corn meal in the biosynthesis of erythromycin]. 1966 Antibiotiki pmid:5984183
Bass TM [Effect of reaction of medium and anaerobic conditions on the action of oletetrine (sigmamycin) and the combination of erythromycin with tetracycline]. 1970 Antibiotiki pmid:5479696
MartinevskiÄ­ IL et al. [Trial use of polymyxin and erythromycin for isolating cultures of the plague microbe in the Kyzyl-Kum]. 1982 Antibiotiki pmid:6295257
Levina AA [Biological properties of staphylococci and the sensitivity to antibiotics of the flora isolated from patients with chronic purulent otitis media]. 1969 Antibiotiki pmid:4998534
Buniatova IM et al. [Study of the action of some antibiotics in combination with the new sulfanilamide compound sulfapyridazine during the acute course of experimental staphylococcal infection]. 1966 Antibiotiki pmid:5184685
Postnikova AA and Kazakov GM [Sequestrotomy combined with antibiotic therapy in treatment of chronic osteomyelitis in children]. 1966 Antibiotiki pmid:5184686
Brinberg SL et al. [Dependence of erythromycin biosynthesis on the active acidity of the medium]. 1976 Antibiotiki pmid:11737
Lobanova W and Brinberg SL [Study of the respiration of erythromycin producer]. 1971 Antibiotiki pmid:5139444
Lobanova VV et al. [Physiological study of the erythromycin-producing actinomyces erythreus strain IAE-1-EFU]. 1970 Antibiotiki pmid:5458631
Liashenko IuI [Effect of penicillin and erythromycin on immunity in angina]. 1982 Antibiotiki pmid:6980620
Zueva VS et al. [Dynamics of the antibiotic sensitivity of the staphylococci in suppurative, inflammatory foci in patients during the period of the hospital stay]. 1975 Antibiotiki pmid:1091206
Ermol'eva EV [Antibiotic preparations and their role in the sharp decline of infection]. 1967 Antibiotiki pmid:4970635
Klimova NE [Study of the absorption and distribution of erythromycin, oleandomycin, tetracycline and oletetrin on the experimental model (chick embryos)]. 1967 Antibiotiki pmid:4970743
Voropaeva SD et al. [Multiple resistance to antibiotics in clinical strains of staphylococci]. 1970 Antibiotiki pmid:5203378
Iats'ko VA [On the dynamics of sensitivity to antibiotics of different microorganisms, isolated from patients of a surgical section]. 1968 Antibiotiki pmid:4971186
VAKULENKO NA [Determination of erythromycin in serum and urine by the agar diffusion method]. 1961 Antibiotiki pmid:13779655
Ganin VS et al. [Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios]. 1971 Antibiotiki pmid:4333292
Turushev VA [Distribution of antibiotic resistance of enteric microblora in cattle on farms of the Amur and Chita region]. 1971 Antibiotiki pmid:4333294
Chernomordik AB and Bass TM [Synergistic and antagonistic effect of chemotherapeutic agents on pathogenic Staphylococci]. 1971 Antibiotiki pmid:4333643
Poliak MS [Combined effect of morphocycline and erythromycin on the pathogenic Clostridia and experimental anaerobic (gaseous) infection]. 1971 Antibiotiki pmid:4333644
BAIKINA VM et al. [STUDIES ON THE TYPICAL COMPOSITION OF ERYTHROMYCIN PRODUCED BY STRAIN NO. 2577 OF ACT. ERYTHREUS]. 1963 Antibiotiki pmid:14076097
Iurenev PN et al. [Complications from antibiotic therapy]. 1975 Antibiotiki pmid:1211892
Kostareva MG et al. [Comparative evaluation of different solvents for erythromycin]. 1971 Antibiotiki pmid:5557387
Belizhenko GG et al. [Study of the joint action of lysozyme and the antibiotics, tetracycline, erythromycin and levomycetin, on Staphylococcus aureus]. 1975 Antibiotiki pmid:1211905
SAVITSKAIA EP [A METHOD FOR THE DETERMINATION OF THE ANTIBIOTIC SENSITIVITY OF RICKETTSIA BURNETI IN VITRO]. 1963 Antibiotiki pmid:14078815
Pavlov EP and Koniaev GA [Effect of rifampicin on transference of drug resistance factors in Staphylococcus aureus]. 1973 Antibiotiki pmid:4685116
MOROZ AF [DIFFERENCES IN THE RESISTANCE OF BACTERIA TO ANTIBACTERIAL SUBSTANCES AND THEIR ROLE IN THE DEVELOPMENT OF DRUG-RESISTANT MICROORGANISMS]. 1964 Antibiotiki pmid:14223632
IMSHENETSKAIA VF [COMPARATIVE EVALUATION OF THE EFFECTIVNESS OF AN ERYTHROMYCIN BASE AND ERYTHROMYCIN ASCORBATE IN EXPERIMENTAL MENINGITIS]. 1963 Antibiotiki pmid:14078820
KISELEV VI [USE OF VARIOUS COMBINATIONS OF ANTIBIOTICS IN THE TREATMENT OF DIPHTHERIAL BACTERIAL CARRIAGE]. 1964 Antibiotiki pmid:14223637
VASILEVA NG [EFFECT OF ANTIBIOTIC THERAPY ON BILIARY MICROFLORA IN CHRONIC CHOLECYSTITIS PATIENTS]. 1964 Antibiotiki pmid:14223638
Ustiuzhanina IIu et al. [Purification of antibiotics by ultrafiltration through semi-permeable membranes]. 1983 Antibiotiki pmid:6418062
Imshenetskaia VF [Erythromycin penetration into the cerebrospinal fluid of patients]. 1976 Antibiotiki pmid:1020930
Voropaeva SD and Fomchenko IV [Study of the selective action of antibiotics in the process of formation of resistant strains of staphylococci]. 1966 Antibiotiki pmid:4231960
CHERNOMORDIK AB et al. [THE SENSITIVITY OF DIPHTHERIA BACTERIA TO THE MACROLIDE ANTIBIOTICS: ERYTHROMYCIN, OLEANDOMYCIN AND SEKAZIN]. 1964 Antibiotiki pmid:14186718
Balashova II and Khomiakova VI [Treatment of staphylococcal infections in children by monomycin, neomycin, erythromycin and oletetrin]. 1967 Antibiotiki pmid:5585720
Tumanian MA and Izvekova AV [The effectiveness of treating infectious complications of radiation sickness with antibiotics]. 1974 Antibiotiki pmid:4462452
ONDRACHEK Z [ON THE EFFECTIVENESS OF CERTAIN ANTIBIOTICS IN THE TREATMENT OF INFECTIOUS BILIARY DISEASES]. 1964 Antibiotiki pmid:14186720
Rusin VN et al. [Equilibrium conditions and the effect of the pH level of the solution on the extractive purification of erythromycin]. 1975 Antibiotiki pmid:237466
Kharchenko GI [The action of antibiotics on the electrokinetic properties of blood serum proteins]. 1966 Antibiotiki pmid:4291643
MOROZ AF [STUDY ON THE COMBINED EFFECT OF MIXTURES OF TETRACYCLINE AND PREPARATIONS FROM THE MACROLID GROUP ON STAPHYLOCOCCI RESISTANT TO VARIOUS ANTIBIOTICS]. 1963 Antibiotiki pmid:14130402
ZAKARIAN LM [ON MODIFIED ANTIBIOTIC SENSITIVITY OF STAPHYLOCOCCI CULTIVATED WITH CANDIDA ALBICANS]. 1964 Antibiotiki pmid:14242807
PASHIN AV [STUDIES ON THE ANTIBIOTIC SENSITIVITY ENTEROPATHOGENIC INTESTINAL BACILLI AND ON ITS RELATION TO THE CARRIAGE OF SYMBIOTIC PHAGES]. 1964 Antibiotiki pmid:14242808
Ivanitskaia LP and Manafova NA [Study of sensitivity to antibiotics in cultures of Anacystis nidulans and Chlorella sp. in relation to their possible use as tests in selection of new biologically active compounds from Actinomycetes]. 1968 Antibiotiki pmid:4180805
MartinevskiÄ­ IL and Stogova AG [Sensitivity to antibiotics of different representatives of family Yersinia]. 1969 Antibiotiki pmid:4181311
Voropaeva SD et al. [Transduction transmission of the extrachromosomal markers of antibiotic resistance in staphylococcal populations]. 1976 Antibiotiki pmid:133633
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
Calvert H et al. Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer. 2014 Anticancer Drugs pmid:24637575
Ohkura K et al. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket. 2009 Anticancer Res. pmid:19414330
Kiso S et al. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. 2000 Sep-Oct Anticancer Res. pmid:11062690
Gunics G et al. Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines. 2001 Jan-Feb Anticancer Res. pmid:11299745
OSWALD EJ et al. IN VITRO ANTISTAPHYLOCOCCAL EFFECTS OF ERYTHROMYCIN COMBINED WITH SEMISYNTHETIC PENICILLINS. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14287966
GUZE LB and KALMANSON GM EFFECT OF ERYTHROMYCIN ON IN VIVO "PROTOPLAST" INFECTION. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14288026
Garrison DW et al. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596165
Duncan IB Development of lincomycin resistance by staphylococci. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596212
TAUBMAN SB et al. EFFECT OF ERYTHROMYCIN ON PROTEIN BIOSYNTHESIS IN BACILLUS SUBTILIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274930
SELL SH and SANDERS RS THERAPY WITH ERYTHROMYCIN ESTOLATE FOR OTITIS MEDIA ASSOCIATED WITH HAEMOPHILUS INFLUENZAE INFECTION. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274999
MOFFETT HL et al. ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14275000
Spizek J et al. Biogenetic relationship of the erythromycins and the lactone of erythromycin B. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883418
Grady JE and Stern KF Penetration of lincomycin into bone. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883427
Rasch JR and Mogabgab WJ Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883484
Whaley HA et al. LL-A0341 A and B, new antibiotics. I. Isolation and characterization. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985292
Wilhelm JM et al. Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:4970204
Perun TJ et al. Conformation of mactolide antibiotics. IV. Nuclear magnetic resonance, circular dichroism, and chemical studies of erythromycin derivatives. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396476
Jones PH et al. Chemical modifications of erythromycin antibiotics. II. Synthesis of 4'-hydroxyerythromycin A. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396478
Zinner SH et al. Erythromycin plus alkalinization in treatment of urinary infections. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396518
Weinstein MJ et al. Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735370
Paterson PY and Madden GM Occurrence and erythromycin susceptibility of penicillin-resistant Viridans streptococci in rheumatic fever patients on oral penicillin prophylaxis. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735376
McGehee RF R et al. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735385
Wick WE and Mallett GE New analysis for the therapeutic efficacy opropionyl erythromycin and erythromycin base. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735386
Kawamata J and Nakajima K Mode of action of colistin. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5327517
Boyd RJ and Godzeski CW Selected antibiotic effects on the L-phase of Protus mirabilis in tissue culture. 1970 Antimicrob Agents Chemother (Bethesda) pmid:5521355
Pérez A et al. Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. 2007 Antimicrob. Agents Chemother. pmid:17638702
Roca I et al. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. 2009 Antimicrob. Agents Chemother. pmid:19581458
L'Hériteau F et al. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. 1995 Antimicrob. Agents Chemother. pmid:7492079
Terashi K et al. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. 2000 Antimicrob. Agents Chemother. pmid:10817732
Drouet M et al. Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics. 2015 Antimicrob. Agents Chemother. pmid:26055373
Furneri PM et al. Levels of flurithromycin in female genital tissue. 1995 Antimicrob. Agents Chemother. pmid:7486945
Yu KW and Neu HC In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics. 1990 Antimicrob. Agents Chemother. pmid:2126695
Banères-Roquet F et al. Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions. 2009 Antimicrob. Agents Chemother. pmid:19164148
Reinert RR et al. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. 2004 Antimicrob. Agents Chemother. pmid:15047546
Gordillo ME et al. In vitro activity of azithromycin against bacterial enteric pathogens. 1993 Antimicrob. Agents Chemother. pmid:8390813
Walzer PD et al. Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. 1992 Antimicrob. Agents Chemother. pmid:1416885
Berry V et al. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. 1998 Antimicrob. Agents Chemother. pmid:9835514
Palmieri C et al. Different genetic elements carrying the tet(W) gene in two human clinical isolates of Streptococcus suis. 2011 Antimicrob. Agents Chemother. pmid:21115784
Hamzehpour MM et al. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. 1995 Antimicrob. Agents Chemother. pmid:8585714
Berti MA and Maccari M Stability of frozen rat plasma containing different antibiotics. 1975 Antimicrob. Agents Chemother. pmid:1211917
Istre GR et al. Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. 1981 Antimicrob. Agents Chemother. pmid:7025754
Secka O et al. Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. 2013 Antimicrob. Agents Chemother. pmid:23263004
Nitu Y et al. In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae. 1974 Antimicrob. Agents Chemother. pmid:4462466